Skip to main content
Premium Trial:

Request an Annual Quote

Philip Chase , Eric Raichle, Jason Rhodes, David Kelley

Premium
Alnylam Pharmaceuticals has added three new members to its management team.
 
Philip Chase has been named vice president of legal, Eric Raichle has been named vice president of human resources, and Jason Rhodes has been named vice president of business development.
 
Chase most recently served as vice president and general counsel at RenaMed Biologics. He holds a JD from Columbia University School of Law.
 
Raichle joins Alnylam from Alkermes, where he was director of human resources. He holds a BA in industrial and organizational psychology from SuffolkUniversity.
 
Rhodes was most recently a partner at biotech venture capital firm Fidelity Biosciences, and he holds an MBA from the Wharton School of the University of Pennsylvania and a BA in history from YaleUniversity.
 

 
Merck said this week that it has named David Kelley as vice president and franchise integrator for diabetes and obesity.
 
Kelley joins Merck from the University of Pittsburgh where he most recently was professor of medicine and director of the university’s Obesity and Nutrition Research Center.
 
At Merck, Kelley will oversee the lead researchers for experimental medicine, imaging, and molecular profiling, and be responsible for coordinating all biomarker, experimental medicine, and imaging activities.
 
Kelley holds an MD from the University of Maryland School of Medicine.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.